Yentreve - Drug Details
📊 Estimates Yentreve Dialyzability By Different_Modalities

Yentreve

Complete Drug Information

Drug Name
Yentreve
Trade Names
Cymbalta
Pregnancy Category
AU: B3
Bioavailability
~50% (32–80%)
Routes of Administration
Oral
Protein Binding
~95%%
Metabolism
Liver, two P450 isozymes, CYP2D6 and CYP1A2
Elimination
10–12 hours
Excretion
70% in urine, 20% in feces
Formula
C18H19NOS
Molar Mass
297.42
Drug Class
Serotonin–norepinephrine reuptake inhibitor (SNRI)
Volume of Distribution
C18H19NOS

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.